Literature DB >> 9373937

Structural studies on the Shigella-like Escherichia coli O121 O-specific polysaccharide.

H Parolis1, L A Parolis, G Olivieri.   

Abstract

The O-specific polysaccharide isolated from the lipopolysaccharide (LPS) of Escherichia coli O121 by mild acid hydrolysis has been studied using mainly NMR spectroscopy. The polysaccharide was treated with mild base to yield a O-deacetylated polysaccharide which contained D-GlcNAc, D-GalNAcA, D-GalNAcAN (2-acetamido-2-deoxy-D-galacturonamide) and D-Qui4NAcGly (where D-Qui4N is 4-amino-4,6-dideoxy-D-glucose) in equimolar proportions. The presence of the amide was confirmed by recording the 1H NMR spectrum of the O-deacetylated polysaccharide at different pH values. The O-acetyl group was located on O-3 of the GalNAcAN and the structure of the polysaccharide can be written as [sequence: see text] This structure is almost identical to that previously reported for the O-specific polysaccharide of Shigella dysenteriae type 7 LPS, the only difference being that O-acetylation is stoichiometric in the latter.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373937     DOI: 10.1016/s0008-6215(97)00178-x

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  9 in total

1.  Sequence of the Escherichia coli O121 O-antigen gene cluster and detection of enterohemorrhagic E. coli O121 by PCR amplification of the wzx and wzy genes.

Authors:  Pina M Fratamico; Connie E Briggs; Danielle Needle; Chin-Yi Chen; Chitrita DebRoy
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.

Authors:  Michael Wetter; Michael Kowarik; Michael Steffen; Paula Carranza; Giampietro Corradin; Michael Wacker
Journal:  Glycoconj J       Date:  2012-10-06       Impact factor: 2.916

3.  The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis.

Authors:  Maria Podbielska; Steven B Levery; Edward L Hogan
Journal:  Clin Lipidol       Date:  2011-04

4.  Novel myelin penta- and hexa-acetyl-galactosyl-ceramides: structural characterization and immunoreactivity in cerebrospinal fluid.

Authors:  Maria Podbielska; Somsankar Dasgupta; Steven B Levery; Wallace W Tourtellotte; Heidi Annuk; Anthony P Moran; Edward L Hogan
Journal:  J Lipid Res       Date:  2010-02-12       Impact factor: 5.922

5.  Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome.

Authors:  Luciano J Melli; Andrés E Ciocchini; Ana J Caillava; Nicolás Vozza; Isabel Chinen; Marta Rivas; Mario F Feldman; Juan E Ugalde; Diego J Comerci
Journal:  J Clin Microbiol       Date:  2014-12-03       Impact factor: 5.948

6.  Biochemical characterization of dTDP-D-Qui4N and dTDP-D-Qui4NAc biosynthetic pathways in Shigella dysenteriae type 7 and Escherichia coli O7.

Authors:  Ying Wang; Yanli Xu; Andrei V Perepelov; Yuanyuan Qi; Yuriy A Knirel; Lei Wang; Lu Feng
Journal:  J Bacteriol       Date:  2007-09-28       Impact factor: 3.490

Review 7.  The structural diversity of carbohydrate antigens of selected gram-negative marine bacteria.

Authors:  Evgeny L Nazarenko; Russell J Crawford; Elena P Ivanova
Journal:  Mar Drugs       Date:  2011-10-14       Impact factor: 6.085

8.  Structure and genetics of Escherichia coli O antigens.

Authors:  Bin Liu; Axel Furevi; Andrei V Perepelov; Xi Guo; Hengchun Cao; Quan Wang; Peter R Reeves; Yuriy A Knirel; Lei Wang; Göran Widmalm
Journal:  FEMS Microbiol Rev       Date:  2020-11-24       Impact factor: 16.408

9.  Structural Studies of the Lipopolysaccharide Isolated from Plesiomonas shigelloides O22:H3 (CNCTC 90/89).

Authors:  Anna Maciejewska; Brygida Bednarczyk; Czeslaw Lugowski; Jolanta Lukasiewicz
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.